Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL

Clinical trial NCT05583071 · RECRUITING

Trial details

NCT number: NCT05583071
Sponsor: University of Cologne
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma

Start date: 2024-08-23
Primary completion: 2027-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.